Discuss the significance of indigenous vaccine development for trans-boundary animal diseases like African Swine Fever in achieving Atmanirbhar Bharat in the veterinary sector.

Q. Discuss the significance of indigenous vaccine development for trans-boundary animal diseases like African Swine Fever in achieving Atmanirbhar Bharat in the veterinary sector. (15 marks, 250-350 words)

African Swine Fever (ASF), caused by ASFV, is a trans-boundary disease with mortality approaching 100% and no treatment; first detected in India in 2020, it has since entrenched itself in the North-East [1]. ICAR-NIHSAD, Bhopal's live-attenuated MA-104 cell line-based vaccine — India's first indigenous ASF vaccine — marks a shift from reactive culling to preventive self-reliance [1][2].

Why trans-boundary diseases demand indigenous capacity - Such diseases spread through porous borders, informal pig trade and wildlife reservoirs, making import-dependent, delayed vaccine access strategically unsafe [1]. - Control so far rested only on rapid diagnosis, culling and biosecurity, an expensive and livelihood-destroying model [1].

Significance of the indigenous ASF vaccine - Economic: Assam lost about ₹276 crore (2020–21) and Mizoram roughly ₹982 crore, affecting over 11,382 households, to ASF [1]. - Social: protects tribal and smallholder pig-rearers of the North-East, for whom pork is both staple protein and primary cash income [1]. - Scientific: use of a widely available, non-proprietary cell line lowers manufacturing cost against costlier global platforms [1]. - Strategic: affordable doses position India as an exporter to ASF-affected Asian neighbours, strengthening agri-diplomacy [1].

Advancing Atmanirbhar Bharat in the veterinary sector - Reduces dependence on foreign biologicals, extending ICAR's earlier record of indigenous livestock vaccines such as IVRI's Classical Swine Fever vaccine [3]. - Validates public-sector high-security animal disease infrastructure (NIHSAD) as a national biosecurity asset [1]. - Industry MoUs signed for technology transfer at ICAR's Foundation Day show a working lab-to-farm commercialisation route [2].

Yet a vaccine alone is insufficient: sustained field validation, cold-chain reach in hill districts, surveillance and farm-level biosecurity must accompany it. Anchoring the vaccine within the National Livestock Mission and a One Health surveillance framework would convert a laboratory success into durable livelihood security, making self-reliance in veterinary biologicals a genuine pillar of rural resilience.

(~320 words)

Sources: 1. Indigenous African Swine Fever (ASF) Vaccine Developed by ICAR Bolsters India's Biosecurity — PIB, Ministry of Agriculture & Farmers Welfare — ASF mortality and absence of treatment, 2020 first detection, MA-104 live-attenuated vaccine by ICAR-NIHSAD, Assam and Mizoram loss figures, affordability and export potential 2. ICAR Celebrates 98th Foundation Day, Reaffirms Commitment to Science-led Agricultural Transformation — release of the ASF vaccine among ICAR technologies; MoUs for industry technology transfer 3. IVRI releases Live attenuated Classical Swine Fever (CSF) cell culture vaccine (Indigenous strain) — PIB — prior indigenous livestock vaccine track record